Retraction: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish
Chuan Yan, Qiqi Yang, Han-Ming Shen, Jan M. Spitsbergen, Zhiyuan Gong
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCholangiocarcinoma and Gallbladder Cancer Studies · RNA modifications and cancer · Cancer-related molecular mechanisms research
This article has been retracted: Multiple figure images in this paper were found to contain internal overlaps and duplications. Specifically, duplicate images were discovered in Figures 1B, 4A, 4B and 5C. The authors were unable to make corrections using the original data. Therefore, with the agreement of all authors, the Scientific Integrity office at Oncotarget has decided to retract this paper.
Original article: Oncotarget. 2017; 8:77096–77109. 77096-77109. https://doi.org/10.18632/oncotarget.20357